200 related articles for article (PubMed ID: 35786910)
1. Degradable ZnS-Supported Bioorthogonal Nanozymes with Enhanced Catalytic Activity for Intracellular Activation of Therapeutics.
Zhang X; Lin S; Huang R; Gupta A; Fedeli S; Cao-Milán R; Luther DC; Liu Y; Jiang M; Li G; Rondon B; Wei H; Rotello VM
J Am Chem Soc; 2022 Jul; 144(28):12893-12900. PubMed ID: 35786910
[TBL] [Abstract][Full Text] [Related]
2. Intracellular Activation of Anticancer Therapeutics Using Polymeric Bioorthogonal Nanocatalysts.
Zhang X; Landis RF; Keshri P; Cao-Milán R; Luther DC; Gopalakrishnan S; Liu Y; Huang R; Li G; Malassiné M; Uddin I; Rondon B; Rotello VM
Adv Healthc Mater; 2021 Mar; 10(5):e2001627. PubMed ID: 33314745
[TBL] [Abstract][Full Text] [Related]
3. Inorganic nanoparticles as scaffolds for bioorthogonal catalysts.
Hirschbiegel CM; Zhang X; Huang R; Cicek YA; Fedeli S; Rotello VM
Adv Drug Deliv Rev; 2023 Apr; 195():114730. PubMed ID: 36791809
[TBL] [Abstract][Full Text] [Related]
4. Supramolecular regulation of bioorthogonal catalysis in cells using nanoparticle-embedded transition metal catalysts.
Tonga GY; Jeong Y; Duncan B; Mizuhara T; Mout R; Das R; Kim ST; Yeh YC; Yan B; Hou S; Rotello VM
Nat Chem; 2015 Jul; 7(7):597-603. PubMed ID: 26100809
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable nanoemulsion-based bioorthogonal nanocatalysts for intracellular generation of anticancer therapeutics.
Nabawy A; Gupta A; Jiang M; Hirschbiegel CM; Fedeli S; Chattopadhyay AN; Park J; Zhang X; Liu L; Rotello VM
Nanoscale; 2023 Aug; 15(33):13595-13602. PubMed ID: 37554065
[TBL] [Abstract][Full Text] [Related]
6. Bioorthogonal nanozymes: an emerging strategy for disease therapy.
Zhang Z; Fan K
Nanoscale; 2022 Dec; 15(1):41-62. PubMed ID: 36512377
[TBL] [Abstract][Full Text] [Related]
7. Control of Intra- versus Extracellular Bioorthogonal Catalysis Using Surface-Engineered Nanozymes.
Das R; Landis RF; Tonga GY; Cao-Milán R; Luther DC; Rotello VM
ACS Nano; 2019 Jan; 13(1):229-235. PubMed ID: 30516966
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte-mediated delivery of bioorthogonal nanozymes for selective targeting of bacterial infections.
Gupta A; Das R; Makabenta JM; Gupta A; Zhang X; Jeon T; Huang R; Liu Y; Gopalakrishnan S; Milán RC; Rotello VM
Mater Horiz; 2021 Nov; 8(12):3424-3431. PubMed ID: 34700339
[TBL] [Abstract][Full Text] [Related]
9. Transition Metal Ru(II) Catalysts Immobilized Nanoreactors for Conditional Bioorthogonal Catalysis in Cells.
Gao Z; Li Y; Xing J; Lu Y; Shao Q; Hu J; Zhao S; He W; Sun B
ACS Appl Mater Interfaces; 2024 Apr; 16(13):15870-15878. PubMed ID: 38520329
[TBL] [Abstract][Full Text] [Related]
10. Progress in controllable bioorthogonal catalysis for prodrug activation.
Liu X; Huang T; Chen Z; Yang H
Chem Commun (Camb); 2023 Oct; 59(84):12548-12559. PubMed ID: 37791560
[TBL] [Abstract][Full Text] [Related]
11. Polymer-Based Bioorthogonal Nanocatalysts for the Treatment of Bacterial Biofilms.
Huang R; Li CH; Cao-Milán R; He LD; Makabenta JM; Zhang X; Yu E; Rotello VM
J Am Chem Soc; 2020 Jun; 142(24):10723-10729. PubMed ID: 32464057
[TBL] [Abstract][Full Text] [Related]
12. Bioorthogonal nanozymes for breast cancer imaging and therapy.
Zhang X; Liu Y; Doungchawee J; Castellanos-García LJ; Sikora KN; Jeon T; Goswami R; Fedeli S; Gupta A; Huang R; Hirschbiegel CM; Cao-Milán R; Majhi PKD; Cicek YA; Liu L; Jerry DJ; Vachet RW; Rotello VM
J Control Release; 2023 May; 357():31-39. PubMed ID: 36948419
[TBL] [Abstract][Full Text] [Related]
13. Modular Fabrication of Bioorthogonal Nanozymes for Biomedical Applications.
Huang R; Hirschbiegel CM; Lehot V; Liu L; Cicek YA; Rotello VM
Adv Mater; 2024 Mar; 36(10):e2300943. PubMed ID: 37042795
[TBL] [Abstract][Full Text] [Related]
14. Intracellular Activation of Bioorthogonal Nanozymes through Endosomal Proteolysis of the Protein Corona.
Zhang X; Liu Y; Gopalakrishnan S; Castellanos-Garcia L; Li G; Malassiné M; Uddin I; Huang R; Luther DC; Vachet RW; Rotello VM
ACS Nano; 2020 Apr; 14(4):4767-4773. PubMed ID: 32227914
[TBL] [Abstract][Full Text] [Related]
15. Nanomaterial-based bioorthogonal nanozymes for biological applications.
Fedeli S; Im J; Gopalakrishnan S; Elia JL; Gupta A; Kim D; Rotello VM
Chem Soc Rev; 2021 Dec; 50(24):13467-13480. PubMed ID: 34787131
[TBL] [Abstract][Full Text] [Related]
16. In situ activation of therapeutics through bioorthogonal catalysis.
Wang W; Zhang X; Huang R; Hirschbiegel CM; Wang H; Ding Y; Rotello VM
Adv Drug Deliv Rev; 2021 Sep; 176():113893. PubMed ID: 34333074
[TBL] [Abstract][Full Text] [Related]
17. A DNA-Gated and Self-Protected Bioorthogonal Catalyst for Nanozyme-Assisted Safe Cancer Therapy.
Zhang Y; Zhang L; Wang W; Deng Q; Liu M; Zhu Z; Liu H; Ren J; Qu X
Angew Chem Int Ed Engl; 2023 Aug; 62(32):e202306395. PubMed ID: 37268594
[TBL] [Abstract][Full Text] [Related]
18. Protection and Isolation of Bioorthogonal Metal Catalysts by Using Monolayer-Coated Nanozymes.
Zhang X; Fedeli S; Gopalakrishnan S; Huang R; Gupta A; Luther DC; Rotello VM
Chembiochem; 2020 Oct; 21(19):2759-2763. PubMed ID: 32400081
[TBL] [Abstract][Full Text] [Related]
19. All-natural gelatin-based bioorthogonal catalysts for efficient eradication of bacterial biofilms.
Nabawy A; Huang R; Luther DC; Zhang X; Li CH; Makabenta JM; Rotello VM
Chem Sci; 2022 Oct; 13(41):12071-12077. PubMed ID: 36349111
[TBL] [Abstract][Full Text] [Related]
20. Charge-Switchable Nanozymes for Bioorthogonal Imaging of Biofilm-Associated Infections.
Gupta A; Das R; Yesilbag Tonga G; Mizuhara T; Rotello VM
ACS Nano; 2018 Jan; 12(1):89-94. PubMed ID: 29244484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]